Cargando…

circIPO7 dissociates caprin-1 from ribosomes and inhibits gastric cancer cell proliferation by suppressing EGFR and mTOR

Circular RNA (circRNA) is a novel RNA molecule characterized by covalently closed loop structure. Since its discovery, researchers have shown that circRNA is not “splicing noise” but a participant of various pathophysiological processes through unique mechanisms. circIPO7, which was identified as an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Jing, Niu, Liling, Hao, Jiaru, Yao, Yuan, Yan, Meinan, Li, Hui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10038803/ https://www.ncbi.nlm.nih.gov/pubmed/36732659 http://dx.doi.org/10.1038/s41388-023-02610-z

Ejemplares similares

Circular RNA circIPO11 drives self-renewal of liver cancer initiating cells via Hedgehog signaling
por: Gu, Yang, et al.
Publicado: (2021)

circEVI5 acts as a miR-4793-3p sponge to suppress the proliferation of gastric cancer
por: Yan, Meinan, et al.
Publicado: (2021)

High-profit IPO strategies: finding breakout IPOs for investors and traders
por: Taulli, Tom, et al.
Publicado: (2013)

EGFR and mTOR as therapeutic targets in glioblastoma
por: Ronellenfitsch, Michael W., et al.
Publicado: (2019)

The nuclear import of ribosomal proteins is regulated by mTOR
por: Kazyken, Dubek, et al.
Publicado: (2014)

Corporate governance in IPO firms
por: Lehmann, Erik E, et al.
Publicado: (2020)

Fucosyltransferase VII promotes proliferation via the EGFR/AKT/mTOR pathway in A549 cells
por: Liang, Jin-xiao, et al.
Publicado: (2017)

Latent class analysis of IPOs in the Nordics
por: Bask, Mikael, et al.
Publicado: (2021)

mTOR-Dependent Cell Proliferation in the Brain
por: Ryskalin, Larisa, et al.
Publicado: (2017)

CircNR3C1 Alleviates Gastric Cancer Development by Inactivating AKT/mTOR
por: Wang, Luben, et al.
Publicado: (2022)

Correction: Latent class analysis of IPOs in the Nordics
Publicado: (2023)

mTOR/PRAS40 interaction: Hypertrophy or proliferation
por: Völkers, Mirko, et al.
Publicado: (2013)

Dual Target of EGFR and mTOR Suppresses Triple-Negative Breast Cancer Cell Growth by Regulating the Phosphorylation of mTOR Downstream Proteins
por: Ma, Jing, et al.
Publicado: (2023)

Dual inhibition of EGFR and mTOR pathways in small cell lung cancer
por: Schmid, K, et al.
Publicado: (2010)

mTOR Promotes Tissue Factor Expression and Activity in EGFR-Mutant Cancer
por: Cong, Ying, et al.
Publicado: (2020)

Retracted: CircNR3C1 Alleviates Gastric Cancer Development by Inactivating AKT/mTOR
por: Healthcare Engineering, Journal of
Publicado: (2023)

CD73 (NT5E) Promotes the Proliferation and Metastasis of Lung Adenocarcinoma through the EGFR/AKT/mTOR Pathway
por: Zhang, Hong, et al.
Publicado: (2022)

Notch and mTOR Signaling Pathways Promote Human Gastric Cancer Cell Proliferation()
por: Hibdon, Elise S., et al.
Publicado: (2019)

Regulation A+ and Other Alternatives to a Traditional IPO
por: Feldman, David
Publicado: (2018)

IPO: a tool for automated optimization of XCMS parameters
por: Libiseller, Gunnar, et al.
Publicado: (2015)

Unicorns’ growth and financial flexibility before and after the IPO
por: Zhou, Man, et al.
Publicado: (2023)

mTOR coordinates protein synthesis, mitochondrial activity and proliferation
por: Morita, Masahiro, et al.
Publicado: (2015)

IPO5 promotes the proliferation and tumourigenicity of colorectal cancer cells by mediating RASAL2 nuclear transportation
por: Zhang, Wenjuan, et al.
Publicado: (2019)

DRAM1 regulates autophagy and cell proliferation via inhibition of the phosphoinositide 3-kinase-Akt-mTOR-ribosomal protein S6 pathway
por: Lu, Ting, et al.
Publicado: (2019)

T cell differentiation protein 2 facilitates cell proliferation by enhancing mTOR-mediated ribosome biogenesis in non-small cell lung cancer
por: Lian, Zhenying, et al.
Publicado: (2022)

mTOR Inhibition Leads to Src-Mediated EGFR Internalisation and Degradation in Glioma Cells
por: Colella, Barbara, et al.
Publicado: (2020)

Targeting EGFR/PI3K/AKT/mTOR Signaling in Hepatocellular Carcinoma
por: Bang, Jieun, et al.
Publicado: (2023)

CircRNA-100338 Is Associated With mTOR Signaling Pathway and Poor Prognosis in Hepatocellular Carcinoma
por: Huang, Xiu-Yan, et al.
Publicado: (2019)

Inhibition of mTOR pathway by everolimus cooperates with EGFR inhibitors in human tumours sensitive and resistant to anti-EGFR drugs
por: Bianco, R, et al.
Publicado: (2008)

TTK regulates proliferation and apoptosis of gastric cancer cells through the Akt‐mTOR pathway
por: Huang, Hongxia, et al.
Publicado: (2020)

mTOR Pathway and mTOR Inhibitors in Head and Neck Cancer
por: Gao, Wei, et al.
Publicado: (2012)

COVID-19: Fear of pandemic and short-term IPO performance
por: Mazumder, Sharif, et al.
Publicado: (2021)

Nuclear Transporter IPO13 Is Central to Efficient Neuronal Differentiation
por: Gajewska, Katarzyna A., et al.
Publicado: (2022)

Competitive threat and strategic disclosure during the IPO quiet period
por: Qiu, Yetaotao, et al.
Publicado: (2022)

EGFR controls bone development by negatively regulating mTOR-signaling during osteoblast differentiation
por: Linder, Markus, et al.
Publicado: (2018)

Co-targeting EGFR and mTOR with gefitinib and everolimus in triple-negative breast cancer cells
por: El Guerrab, Abderrahim, et al.
Publicado: (2020)

Interactions of EGFR/PTEN/mTOR-Pathway Activation and Estrogen Receptor Expression in Cervical Cancer
por: Bartl, Thomas, et al.
Publicado: (2023)

CircCASC15-miR-100-mTOR may influence the cervical cancer radioresistance
por: Yao, Tingting, et al.
Publicado: (2022)

Myelination and mTOR
por: Figlia, Gianluca, et al.
Publicado: (2017)

mTOR signaling pathway and mTOR inhibitors in cancer: progress and challenges
por: Zou, Zhilin, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ij98rvovb0ami1mvqmto7kmfv9